WO2008035086A3 - Synthesis of leukotriene compounds - Google Patents
Synthesis of leukotriene compounds Download PDFInfo
- Publication number
- WO2008035086A3 WO2008035086A3 PCT/GB2007/003581 GB2007003581W WO2008035086A3 WO 2008035086 A3 WO2008035086 A3 WO 2008035086A3 GB 2007003581 W GB2007003581 W GB 2007003581W WO 2008035086 A3 WO2008035086 A3 WO 2008035086A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- leukotriene
- synthesis
- compounds
- present
- montelukast
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C29/00—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring
- C07C29/36—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring increasing the number of carbon atoms by reactions with formation of hydroxy groups, which may occur via intermediates being derivatives of hydroxy, e.g. O-metal
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C51/00—Preparation of carboxylic acids or their salts, halides or anhydrides
- C07C51/347—Preparation of carboxylic acids or their salts, halides or anhydrides by reactions not involving formation of carboxyl groups
- C07C51/36—Preparation of carboxylic acids or their salts, halides or anhydrides by reactions not involving formation of carboxyl groups by hydrogenation of carbon-to-carbon unsaturated bonds
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C67/00—Preparation of carboxylic acid esters
- C07C67/08—Preparation of carboxylic acid esters by reacting carboxylic acids or symmetrical anhydrides with the hydroxy or O-metal group of organic compounds
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C67/00—Preparation of carboxylic acid esters
- C07C67/30—Preparation of carboxylic acid esters by modifying the acid moiety of the ester, such modification not being an introduction of an ester group
- C07C67/31—Preparation of carboxylic acid esters by modifying the acid moiety of the ester, such modification not being an introduction of an ester group by introduction of functional groups containing oxygen only in singly bound form
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/18—Halogen atoms or nitro radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/07—Optical isomers
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Quinoline Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
The present invention relates to the synthesis of leukotriene receptor agonist compounds and to novel intermediates employed in their preparation. Leukotriene agonists are used in the treatment of asthma, as well as other conditions mediated by leukotrienes such as inflammation and allergies. A compound of particular interest is montelukast and the present invention describes an improved process for making montelukast and similar compounds.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0618703.3A GB0618703D0 (en) | 2006-09-22 | 2006-09-22 | Synthesis of leikotriene compounds |
GB0618703.3 | 2006-09-22 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2008035086A2 WO2008035086A2 (en) | 2008-03-27 |
WO2008035086A3 true WO2008035086A3 (en) | 2008-06-26 |
Family
ID=37421455
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/GB2007/003581 WO2008035086A2 (en) | 2006-09-22 | 2007-09-21 | Synthesis of leukotriene compounds |
Country Status (2)
Country | Link |
---|---|
GB (1) | GB0618703D0 (en) |
WO (1) | WO2008035086A2 (en) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2008510840A (en) | 2005-07-05 | 2008-04-10 | テバ ファーマシューティカル インダストリーズ リミティド | Purification of Montelukast |
CN104109123B (en) * | 2013-04-16 | 2016-12-07 | 浙江奥翔药业股份有限公司 | For midbody compound synthesizing montelukast and preparation method thereof |
CN103288695B (en) * | 2013-06-18 | 2016-01-13 | 成都迈斯克医药科技有限公司 | The preparation method of 1-thiopurine methyltransferase cyclopropaneacetic acid |
CN104592111B (en) * | 2015-02-13 | 2015-11-11 | 江苏欧信医药化工有限公司 | A kind of synthetic method of montelukast sodium intermediate |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0480717A1 (en) * | 1990-10-12 | 1992-04-15 | Merck Frosst Canada Inc. | Unsaturated hydroxyalkylquinoline acids as leukotriene antagonists |
WO1995018107A1 (en) * | 1993-12-28 | 1995-07-06 | Merck & Co., Inc. | Process for the preparation of leukotriene antagonists |
US5523477A (en) * | 1995-01-23 | 1996-06-04 | Merck & Co., Inc. | Process for the preparation of 1-(thiomethyl)-cyclopropaneacetic acid |
-
2006
- 2006-09-22 GB GBGB0618703.3A patent/GB0618703D0/en not_active Ceased
-
2007
- 2007-09-21 WO PCT/GB2007/003581 patent/WO2008035086A2/en active Application Filing
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0480717A1 (en) * | 1990-10-12 | 1992-04-15 | Merck Frosst Canada Inc. | Unsaturated hydroxyalkylquinoline acids as leukotriene antagonists |
WO1995018107A1 (en) * | 1993-12-28 | 1995-07-06 | Merck & Co., Inc. | Process for the preparation of leukotriene antagonists |
US5523477A (en) * | 1995-01-23 | 1996-06-04 | Merck & Co., Inc. | Process for the preparation of 1-(thiomethyl)-cyclopropaneacetic acid |
Non-Patent Citations (2)
Title |
---|
GRAUL L ET AL: "Montelukast sodium, MK-476, MK-0476, L-706631, Singulair", DRUGS OF THE FUTURE, BARCELONA, ES, vol. 22, no. 10, 1997, pages 1103, XP008082254, ISSN: 0377-8282 * |
LABELLE M ET AL: "Discovery of MK-0476, a potent and orally active leukotriene D4 receptor antagonist devoid of peroxisomal enxyme induction", BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, OXFORD, GB, vol. 5, no. 3, 2 February 1995 (1995-02-02), pages 283 - 288, XP004817884, ISSN: 0960-894X * |
Also Published As
Publication number | Publication date |
---|---|
WO2008035086A2 (en) | 2008-03-27 |
GB0618703D0 (en) | 2006-11-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2007041077A3 (en) | Heterocyclic amide derivatives as rxr agonists for the treatment of dyslipidemia, hypercholesterolemia and diabetes | |
WO2011149999A3 (en) | Method for preparing antibodies having improved properties | |
WO2009095933A3 (en) | Improved and novel process for the preparation of bosentan | |
WO2010049454A3 (en) | Antimicrobial composition from copepods | |
WO2007041076A3 (en) | 1,2,3,5-tetrahydro-cyclopental[c]quinolin-4-one derivatives as rxr agonists for the treatment of dyslipidemia, hypercholesterolemia and diabetes | |
WO2007041112A3 (en) | Dihydro-[1h]-quinolin-2-one derivatives as rxr agonists for the treatment of dyslipidemia, hypercholesterolemia and diabetes | |
WO2006087143A8 (en) | Novel processes for the preparation of a 2h-chromene | |
WO2009104021A3 (en) | Novel polymorphs and processes for their preparation | |
WO2008139452A3 (en) | Selective bromination of perylene diimides and derivatives thereof under mild conditions | |
WO2008032099A3 (en) | Process for the preparation of montelukast, and intermediates therefor | |
MA31834B1 (en) | 5 - [(3,3,3-TRIFLUORO-2-HYDROXY-1-ARYLPROPYL) AMINO] -1H-QUINOLIN-2-ONES, PROCESS FOR THE PRODUCTION THEREOF AND THEIR USE AS ANTI-INFLAMMATORY | |
WO2009068463A3 (en) | Process for the preparation of isoindole derivatives as well as a process for the preparation of their intermediates | |
WO2008035086A3 (en) | Synthesis of leukotriene compounds | |
WO2007132354A3 (en) | Process for preparing voriconazole, new polymorphic form of intermediate thereof, and uses thereof | |
WO2009004643A3 (en) | An improved process for preparation of (s)-pregabalin and intermediates thereof | |
WO2007047671A3 (en) | Tetrahydroquinolines, synthesis thereof, and intermediates thereto | |
WO2010004578A3 (en) | Novel and improved processes for the preparation of paliperidone | |
WO2008065282A3 (en) | Substituted pyrazoles, compositions containing these, method of production and use | |
WO2012029077A3 (en) | Process for preparing fluticasone propionate/furoate | |
MX2010001864A (en) | Method for the preparation of montelukast acid in ionic liquid medium. | |
WO2009009122A3 (en) | Derivatives of urea and related diamines, methods for their manufacture, and uses therefor | |
WO2008033935A3 (en) | Vinorelbine derivatives | |
WO2007137098A3 (en) | Sulfonyl-substituted bicyclic compounds as modulators of ppar | |
WO2009061875A3 (en) | Processes and intermediates for producing aminobenzimidazole ureas | |
WO2010079506A3 (en) | Pharmaceutical composition of aripiprazole |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 07823912 Country of ref document: EP Kind code of ref document: A2 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 07823912 Country of ref document: EP Kind code of ref document: A2 |